Journal of Feline Medicine and Surgery最新文献

{"title":"Evaluation of factors associated with recurrence in 47 cats undergoing balloon dilation for nasopharyngeal stenosis.","authors":"Aki Fujiwara-Igarashi, Sho Goto, Takafumi Ohshima, Shota Sakanoue, Tetsuya Taniguchi, Haruyoshi Tetsu, Yuta Nakazawa, Yasuyuki Endo","doi":"10.1177/1098612X251340050","DOIUrl":"10.1177/1098612X251340050","url":null,"abstract":"<p><p>ObjectivesThis study aimed to evaluate factors associated with recurrence of clinical signs after balloon dilation in cats with nasopharyngeal stenosis (NPS).MethodsA retrospective multicentre study was conducted using data collected from the medical records of cats treated for NPS using balloon dilation. A total of 47 cats, each with a follow-up period of ⩾180 days, were included in the analysis of progression-free interval (PFI) and hazard ratio (HR) using Kaplan-Meier and Cox proportional hazards analyses.ResultsMultiple balloon dilations were planned for 26/47 cats. In total, 14 cats received three procedures and 12 cats received two. The dilations were performed at a median interval of 35 days (interquartile range [IQR] 29-39, range 15-127), regardless of transient recurrence. A single dilation was planned for the remaining 21 cats. Recurrence after the final balloon dilation occurred in 18/47 (38%) cats; in these cases, the median time from the final dilation to recurrence was 42 days (IQR 18-142, range 6-2303). The median PFI was 2303 days (range 6-2704), with 6-month and 1-year recurrence-free rates of 70% and 65%, respectively. Multivariate analysis revealed that performing planned multiple dilations was the only variable associated with improved PFI (HR 0.06, 95% confidence interval [CI] 0.01-0.30; <i>P</i> < 0.001). Specifically, cats undergoing planned multiple dilations had higher 6-month (92% vs 43%) and 1-year (88% vs 38%) progression-free rates than those undergoing a single dilation. No significant correlation was observed between PFI and the number of balloon dilation treatments.Conclusions and relevanceBalloon dilation repeated two or three times, regardless of any recurrence of signs, may assist in the long-term resolution of NPS in some cases.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251340050"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of hypocobalaminaemia and hypercobalaminaemia in a referral population of cats in the UK and its relevance to clinical presentation, diagnosis and prognosis.","authors":"Simona Borgonovi, Will Bayton","doi":"10.1177/1098612X251341539","DOIUrl":"10.1177/1098612X251341539","url":null,"abstract":"<p><p>ObjectivesThis study aimed to assess the prevalence of hypocobalaminaemia (B12 <400 pg/ml) and hypercobalaminaemia (B12 >1000 pg/ml), describe the clinicopathological abnormalities and the diagnostic imaging findings in a referral population of cats in the UK, and identify the underlying disease processes associated with both conditions.MethodsA retrospective study of cats that had their serum cobalamin concentration assessed between December 2016 and December 2023 at a single referral hospital; 216 cats were included. Patient outcome was established from the clinical records.ResultsA total of 76 (35%) cats had hypocobalaminaemia and 67 (31%) cats had hypercobalaminaemia. The most common diagnoses were chronic enteropathy (CE) in 39/76 (51%) hypocobalaminaemic cats and 39/67 (58%) hypercobalaminaemic cats (<i>P</i> = 0.001), and high-grade lymphoma in 14/76 (18%) hypocobalaminaemic cats and 11/67 (16%) hypercobalaminaemic cats (<i>P</i> = 0.438). The most common clinical signs were chronic vomiting in 36/76 (47%) hypocobalaminaemic cats and 24/67 (36%) hypercobalaminaemic cats (<i>P</i> = 0.005), hyporexia in 40/76 (53%) hypocobalaminaemic cats and 21/67 (31%) hypercobalaminaemic cats (<i>P</i> <0.001), and chronic diarrhoea in 12/76 (16%) hypocobalaminaemic cats and 21/67 (31%) hypercobalaminaemic cats (<i>P</i> = 0.001). The most common abnormalities identified on abdominal ultrasound were lymphadenomegaly and thickened intestines in 49/76 (64%) hypocobalaminaemic cats and 28/67 (42%) hypercobalaminaemic cats (<i>P</i> = 0.0025). Median survival time was 274 days in the hypocobalaminaemic group and 711 days in the hypercobalaminaemic group (<i>P</i> = 0.001). The hypocobalaminaemic cats exhibited significantly reduced survival time compared with hypercobalaminaemic cats (odds ratio 2.4 vs 0.4, respectively) (<i>P</i> <0.001).Conclusions and relevanceThis study suggests that cobalamin has limited diagnostic utility in differentiating between underlying disease processes; chronic diarrhoea and CE are more common in hypercobalaminaemic cats in contrast with the previous literature. Hypocobalaminaemia is associated with reduced survival in this cohort of cats; therefore, early cobalamin supplementation is recommended.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251341539"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12260385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medial humeral epicondylitis: a retrospective case series of nine cats (17 elbows).","authors":"Mary Baldeon, Karen Lisette Perry","doi":"10.1177/1098612X251347952","DOIUrl":"10.1177/1098612X251347952","url":null,"abstract":"<p><p><i>Case series summary</i> The aim of this study was to describe the clinical findings, diagnostic results and response to both non-surgical and surgical therapy in cats with medial humeral epicondylitis (MHE). The medical records of one institution were searched for cats with a radiographically confirmed diagnosis of MHE where non-surgical therapy alone or both non-surgical and surgical therapy had been trialed. Nine cats (17 elbows) were included. None of the cats had a history of outdoor access. Orthopedic examination revealed pain upon palpation over the medial epicondyle (n = 15), elbow pronation/supination (n = 7) or carpal flexion (n = 7) and palpable mineralization distal to the medial epicondyle (n = 7). Epicondylitis was radiographically graded as mild (n = 8), moderate (n = 7) or severe (n = 2). CT was performed in 10 elbows and revealed additional information in seven, including intra-articular mineralized bodies in five elbows. Ultrasound was performed in four elbows and revealed fluid surrounding the flexor carpi ulnaris muscle. After non-surgical management, four cats showed no response, four showed a partial response and one showed a complete response. Cats with less advanced radiographic changes appeared to show more favorable responses. Four cats (seven elbows) underwent surgical treatment with ulnar neuritis being evident in all. Lameness resolved postoperatively in three cats (five elbows).<i>Relevance and novel information</i> An insidious onset of moderate-grade lameness associated with pain on palpation caudodistal to the medial epicondyle should increase the index of suspicion for MHE and prompt assessment for the presence of palpable mineralization and pain on carpal flexion. Ulnar neuritis is common in cats with MHE and they frequently present with free articular mineralized bodies. Radiographs can only detect advanced or chronic stages of MHE, by which time non-surgical management is likely to be ineffective. Earlier diagnosis using ultrasound may improve the prognosis after non-surgical management.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251347952"},"PeriodicalIF":2.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"FelineVMA meeting the physical and emotional needs of indoor cats position statement.","authors":"","doi":"10.1177/1098612X251353656","DOIUrl":"10.1177/1098612X251353656","url":null,"abstract":"","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251353656"},"PeriodicalIF":2.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144731603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Standardized classification of synchronous gastrointestinal small cell lymphoma and gastrointestinal mast cell tumors in 15 cats.","authors":"Ann E Hohenhaus, Danielle Hudak, Taryn A Donovan, Christof A Bertram, Heather Daverio","doi":"10.1177/1098612X251341769","DOIUrl":"10.1177/1098612X251341769","url":null,"abstract":"<p><p>ObjectivesSynchronous primary tumors have been defined as two or more concurrent, yet independent tumors diagnosed within 6 months or less. The primary objective of this study was to investigate the occurrence and clinical findings in cats with synchronous gastrointestinal (GI) small cell lymphoma (SCL) and GI mast cell tumor (MCT) at two referral hospitals. A secondary objective was to classify these tumors as distinct or mixed, and if mixed, categorize them histomorphologically as collision or combined tumors based on standardized definitions informed by literature review.MethodsThe databases of the Schwarzman Animal Medical Center (AMC) and University of Veterinary Medicine in Vienna, Austria (Vetmeduni) were searched between January 2012 and December 2022 for cats with synchronous GI SCL and GI MCT. Clinical findings, treatment and outcome were abstracted from medical records. Biopsy or autopsy reports and, when available, slides and/or histopathology images indicating the presence of a synchronous GI SCL and GI MCT were reviewed by two board-certified pathologists.ResultsA total of 15 cats were diagnosed with synchronous GI SCL and GI MCT, representing 4.3% of 329 cats with GI SCL in the AMC population. This study identified 15 cats with a total of 18 synchronous tumors. Six cats had tumors classified as distinct tumors and six as combined. Three cats had both distinct and combined tumors. Survival in this group of cats was in the range of 8-1189 days.Conclusions and relevanceThis is the first report to classify synchronous tumors in cats as distinct and combined tumors. The results of this study indicate a wide range of survival times for cats with synchronous GI SCL and GI MCT, suggesting that despite the diagnosis of synchronous tumors, the outcome is similar to cats with either GI SCL or GI MCT.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251341769"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277675/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144674954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Osteoarthritis in cats: what we know, and mostly, what we don't know. . . yet.","authors":"Manuela Lefort-Holguin, Aliénor Delsart, Marilyn Frézier, Laurie Martin, Colombe Otis, Maxim Moreau, Aude Castel, Bertrand Lussier, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Eric Troncy","doi":"10.1177/1098612X251347999","DOIUrl":"10.1177/1098612X251347999","url":null,"abstract":"<p><p>Osteoarthritis (OA) is a degenerative joint disease that is considered the primary source of chronic pain in cats, affecting well over a quarter of the feline population. Despite its prevalence, detection and diagnosis rates remain low, as many owners are unaware of the signs of feline OA. There is limited knowledge regarding the management of feline OA, with only 29 publications available, many of which lack rigorous methodology. Furthermore, most research focuses on the efficacy of non-steroidal anti-inflammatory drugs, while proposed alternatives to alleviate feline OA pain - such as food restriction, weight loss, adjunctive musculoskeletal treatments with biologics, physiotherapeutic modalities and lifestyle changes - are primarily based on human clinical studies and veterinary research on other species, which introduces a high risk of bias. New promising avenues are being explored with anti-nerve growth factor monoclonal antibodies; however, the long-term effects of repetitive administration, optimal conditions for administration and specific indications have yet to be described. Research from the <i>Groupe de recherche en pharmacologie animale du Québec</i> (GREPAQ) on pharmacological and non-pharmacological therapies for feline OA suggests that a shift in the OA management paradigm may be warranted. An omega-3 enriched diet has demonstrated therapeutic efficacy comparable to standard pharmacological treatments, without side effects and with high compliance. In addition, it was equally effective for cats with severe OA as for those with moderate OA. By establishing a theoretical framework for feline OA management based on robust scientific evidence, veterinarians will be better equipped to select treatments tailored to the diagnosed (or suspected) manifestations and mechanisms of OA pain, ultimately improving the health and well-being of their feline patients. Future research should explore the concomitant use of different therapeutic approaches, as they may offer superior outcomes compared with a single treatment through additive or synergistic effects.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251347999"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144674953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Physical rehabilitation of cats: 2. Treatment therapies and exercises.","authors":"Mary Ellen Goldberg","doi":"10.1177/1098612X251334555","DOIUrl":"10.1177/1098612X251334555","url":null,"abstract":"<p><strong>Practical relevance: </strong>Physical rehabilitation (physiotherapy) involves restoring a patient's movement and function following an injury, illness or trauma. It can be used for acute and chronic conditions and, in some cases, the techniques are used as a preventive treatment. Some therapies can also provide pain relief, which can be especially helpful when analgesic drugs are contraindicated in a patient. In recent years, there has been increasing interest in the application of physiotherapy to small animals, and while physical rehabilitation has traditionally been used more commonly for canine than feline patients, as cats can benefit just as much as dogs, this trend is changing. A multidisciplinary team is involved and identifying when a cat is painful and prioritizing therapies accordingly is crucial.</p><p><strong>Clinical challenges: </strong>Cats are not accustomed to regular handling or restraint and tend to become uninterested and frustrated quickly, which means they are often perceived as poor candidates for physiotherapy referral. As well as a cat's temperament, there are physical factors that may limit or exclude particular therapies; for instance, a cat's level of cardiovascular health. There can also be much variation with the success of different therapies - what works well in one individual might have no effect in another.</p><p><strong>Aims: </strong>This article, the second in a two-part series, discusses individual therapies and exercises for physical rehabilitation. This follows on from Part 1, which discusses the most common painful conditions in cats that can benefit from physical rehabilitation, as well as the importance of prioritizing the type of therapy depending on the individual patient.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 7","pages":"1098612X251334555"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12227875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144553741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immunohistochemical evaluation of cyclooxygenase-2 expression in feline nasal malignant epithelial tumours.","authors":"Nicolas Diop, Aude M Canonne, Hélène Huet, Edouard Reyes-Gomez, Jérémy Béguin","doi":"10.1177/1098612X251314336","DOIUrl":"10.1177/1098612X251314336","url":null,"abstract":"<p><p>ObjectivesCyclooxygenase-2 (COX-2), a pivotal enzyme in the cyclooxygenase family, plays a critical role in carcinogenesis. While its expression is well documented in various neoplasms in humans and dogs, data on COX-2 expression in feline neoplasms, particularly nasal malignant epithelial tumours, is limited. This study aimed to evaluate COX-2 expression in feline nasal malignant epithelial tumours through immunohistochemistry. We hypothesised that these tumours would exhibit COX-2 expression, consistent with findings in humans and dogs.MethodsFormalin-fixed, paraffin-embedded biopsy samples from feline nasal malignant epithelial tumours were retrospectively analysed for COX-2 expression by immunohistochemistry. Biopsies from cats previously treated with non-steroidal anti-inflammatory drugs were excluded. Immunohistochemistry was performed with a monoclonal rabbit antibody, with feline renal macula densa cells serving as the positive control. The immunoreactive score (IRS) combined a semiquantitative estimation of immunolabelled neoplastic cells with labelling intensity. Scores in the range of 0-1 were classified as negative, 2-3 as low, 4-8 as intermediate and greater than 8 as high COX-2 expression levels.ResultsA total of 18 feline nasal biopsies (nine adenocarcinomas, seven carcinomas, one squamous cell carcinoma and one mucinous carcinoma) were included. Clinical signs included nasal discharge, sneezing, epistaxis and inspiratory dyspnoea. COX-2 expression was not detected in any case (IRS = 0). Follow-up data were available for 7/18 cats. The overall median survival time after diagnosis in our cohort was 667 days (range 0-1642).Conclusions and relevanceIn contrast to canine nasal malignant epithelial tumours, COX-2 expression was not observed in feline nasal malignant epithelial tumours. These results suggest species-specific differences in COX-2 expression in nasal malignant epithelial tumours. Further studies evaluating other carcinogenesis pathways, such as vascular endothelial growth factor or platelet-derived growth factor, seem crucial to better understand feline nasal malignant epithelial tumours and to improve their therapeutic management.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 6","pages":"1098612X251314336"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144302236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A retrospective descriptive study of colorectal large or intermediate cell lymphoma in cats managed with surgical resection and/or medical management.","authors":"Katerina Holenova, Petros Odatzoglou, Frances Taylor","doi":"10.1177/1098612X251338641","DOIUrl":"10.1177/1098612X251338641","url":null,"abstract":"<p><p>ObjectivesThe current standard-of-care treatment for feline gastrointestinal intermediate- or large-cell lymphoma is systemic chemotherapy. There is some evidence that feline lymphoma patients with a solitary gastrointestinal mass may benefit from excisional surgery followed by chemotherapy; however, most studies of feline gastrointestinal lymphoma combine various stages and anatomical sites of the disease. Studies indicating different behaviour of feline gastrointestinal lymphoma depending on its anatomical location have been published, and significantly longer survival times have been seen in canine colorectal lymphoma. The aim of the present study was therefore to describe the signalment, treatment and outcome of cats with intermediate- or large-cell lymphoma in the colorectal region.MethodsThe medical records of three veterinary hospitals were retrospectively searched for cats diagnosed with a colorectal intermediate- or large-cell lymphoma. The data were collected and subjected to a univariate analysis, and median values were calculated for each of the variables of interest. Median survival times were estimated using the Kaplan-Meier method.ResultsA total of 11 cats were included in the study, with the most common presenting signs being haematochezia, hyporexia, diarrhoea and weight loss. Different treatment strategies and their combinations were used, leading to an overall median survival time of 177 days, with a difference seen between chemotherapy only (29 days) and a combination of surgery and chemotherapy (972 days). Two cats treated with both surgery and chemotherapy were alive at more than 20 months after diagnosis.Conclusions and relevanceThis is the first study to describe specifically cases of cats with intermediate- to large-cell colorectal lymphoma. Even though the number of cases was limited because of the rarity of the disease, the data indicate multimodal treatment might be beneficial in these cases.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 6","pages":"1098612X251338641"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12206256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144528239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Body stalk anomalies and their relationship to amniotic band disruption complex in six cats.","authors":"Nieves Martín-Alguacil, José M Cozar, Luis Avedillo","doi":"10.1177/1098612X251341068","DOIUrl":"10.1177/1098612X251341068","url":null,"abstract":"<p><p>ObjectivesThe aim of this study was to investigate the appearance of body stalk anomalies (BSAs) and amniotic band disruption complex (ABDC) in cats (<i>Felis catus</i>), classify these congenital conditions using a system originally developed for humans and pigs, and provide new insights into the aetiopathogenesis.MethodsSix cats suspected of having BSAs and/or ABDC were examined. The classification system for BSA, which includes eight types, was applied to these cases. Detailed observations were made regarding physical deformities, presence of amniotic adhesions and degree of impairment. A comparative analysis with similar conditions in pigs and humans was carried out to highlight differences and similarities.ResultsTwo of the eight BSA classifications used in human and porcine congenital anomalies were detected in the six cats. In the studied cases, the degree of severity was lower than in pigs. The abnormalities associated with BSAs were attributed to the effect of amniotic bands on already formed organs or to the disruption of organ development, leading to a cascade of abnormal events.Conclusions and relevanceThis study is the first to describe and classify BSAs and ABDC in cats and provides valuable insights into these congenital anomalies. The findings highlight significant differences and similarities between cats and other species, particularly pigs. Understanding the aetiopathogenesis of these conditions is essential to improve clinical management and prognosis. Surgical correction and supportive care can improve the quality of life of affected cats, depending on the severity of the condition. Continued research and collaboration are essential to advance the prevention, diagnosis and treatment of BSAs and ABDC in cats, with wider implications for congenital anomalies across species.Plain language summaryThis study aims to explore body stalk anomalies (BSAs) and amniotic band disruption complex (ABDC) in cats (<i>Felis catus</i>). It classifies these conditions using a system developed for humans and pigs and seeks to understand their causes and management in cats. Six cats with suspected BSAs and/or ABDC were examined. The classification system for BSA, which includes eight types, was applied to these cases. Observations focused on physical deformities, amniotic adhesions and the severity of the conditions. Comparisons were made with similar conditions in pigs and humans. Two of the eight BSA classifications used in human and porcine congenital anomalies were detected in the six cats. In this study, the severity of the condition in cats was lower compared with pigs. The abnormalities were caused by amniotic bands affecting already-formed organs or disrupting organ development, leading to a series of abnormal events. This is the first study to describe and classify BSAs and ABDC in cats. It provides new insights into these congenital conditions and highlights differences and similarities with other species. Surgical correction and ","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"27 6","pages":"1098612X251341068"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144475518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}